Study on the differences of voice/facial expression/behavior pattern between patients with major depressive disorder and bipolar disorder

Study on the differences of voice/facial expression/behavior pattern between patients with major depressive disorder and bipolar disorder - Distinguish between patients with major depressive disorder and those with bipolar disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027139

Enrollment

Registered

2017-04-27

Start date

2017-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder (MDD) Bipolar disorder (BP)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria are included in this study: 1) Those treated as an outpatient or healthy adults. 2) Those aged between 20 and 75 at the time of signing the informed consent. 3) Those who have been diagnosed or newly diagnosed with MDD or BP as defined by DSM-5 criteria (excluding unipolar manic episodes), or healthy adults. 4) Those deemed to be able to understand and comply with the protocol details according to the decision of the principal investigator. 5) Those who can sign and date the written informed consent prior to the initiation of any of the study procedures.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria are excluded from this study: 1) Those with complications or past history of any of the following psychiatric disorders and/or neurological disorders: -Those with any psychiatric disorders other than MDD or BP (as defined by DSM-5). -Those with MDD, BP, or schizophrenia accompanied by psychotic features, or with complications or history of other psychotic disorders (including substance-related mental disorders, or mental disorders caused by general physical diseases) as defined by DSM-5. 2) Those who are at significant risk of suicide. 3) Those who have a history of severe allergy or hypersensitivity to drugs. 4) Those who are pregnant or lactating or have pregnancy wishes when obtaining the informed consent. 5) Those who are unsuitable for this study for any other reasons according to decisions by the principal investigator or other investigators.

Design outcomes

Primary

Measure	Time frame
Compare the scores of Montgomery-Asberg Depression Rating Scale (MADRS) and the data of voice/facial expression/behavior pattern.	—

Secondary

Measure	Time frame
Compare the scores of multiple measures (YMRS, HSDS/HSAS, DSST, PDQ-5) and the data of voice/facial expression/behavior pattern.	—

Countries

Japan

Contacts

Public ContactYoshinori Watanabe

Medical Corporation Jisenkai Himorogi Psychiatric Institute

watanabe@himorogi.org03-5946-8586

Outcome results